Normal FEV1 without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis

Publication date

2025-12-01

Authors

Couillard, Simon
Mailhot-Larouche, Samuel
Meulmeester, Fleur L.
Brusselle, Guy
Lachapelle, Philippe
Beasley, Richard W.
Sont, Jacob K.
Steyerberg, Ewout WORCID 0000-0002-7787-0122
Pavord, Ian D.
Lugogo, Njira

Editors

Advisors

Supervisors

Document Type

Letter

Collections

License

taverne

Abstract

Keywords

Taverne, Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine

Citation

Couillard, S, Mailhot-Larouche, S, Meulmeester, F L, Brusselle, G, Lachapelle, P, Beasley, R W, Sont, J K, Steyerberg, E W, Pavord, I D, Lugogo, N & ORACLE2 Consortium 2025, 'Normal FEV 1 without Reversibility in Asthma Trials : A Placebo Patient-Level Meta-Analysis', American journal of respiratory and critical care medicine, vol. 211, no. 12, pp. 2396-2399. https://doi.org/10.1164/rccm.202503-0721RL